Autres langues Repligen Corporation

Actions

RGEN

US7599161095

Equipement, fournitures et distribution médicale

Temps réel estimé Cboe BZX 20:27:40 10/09/2026			Varia. 5j.	Varia. 1 janv.
162,62 ^USD	-1,47%		-4,31%	-0,95%

09/09	Transcript : Repligen Corporation Presents at Wells Fargo 21st Annual Healthcare Conference, Sep-09-2026 01:30 PM
09/09	Repligen Corporation : UBS réitère son opinion positive sur le titre	ZM

Autres langues

01/09	Afternoon Meeting: La renta fija empaña el inicio de septiembre
01/09	Bonds spoil September's opening
01/09	Analyst recommendations: Duolingo, Robinhood, Adobe, CrowdStrike, Salesforce…
26/08	Repligen Corporation to Present at Wells Fargo 21st Annual Healthcare Conference
24/08	Top Midday Decliners
24/08	Azenta Names Board Member Martin Madaus as Interim CEO
29/07	Tranche Update on Repligen Corporation's Equity Buyback Plan announced on June 18, 2008.
29/07	Tranche Update on Repligen Corporation's Equity Buyback Plan announced on December 7, 2023.
29/07	Repligen's Diversity of Growth Drivers Support Return to Mid-Teens Organic Sales Growth, RBC Says
28/07	Repligen Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026
28/07	Repligen's Q2 Adjusted Earnings, Revenue Increase; 2026 Outlook Raised
28/07	(RGEN) Repligen Expects 2026 Adjusted EPS Range $2.03-$2.09, vs. FactSet Est of $2.00
28/07	Earnings Flash (RGEN) Repligen Corporation Reports Q2 Revenue $204.1M, vs. FactSet Est of $201.6M
28/07	Earnings Flash (RGEN) Repligen Corporation Posts Q2 Adjusted EPS $0.54 per Share, vs. FactSet Est of $0.45
28/07	Repligen: Q2 Earnings Snapshot
28/07	Repligen Reports Second Quarter 2026 Financial Results and Updates Full Year 2026 Financial Guidance
22/07	Top Midday Stories: Trump Threatens Retaliation for Attacks in Strait of Hormuz; AMD to Supply MI450 GPUs to Anthropic
22/07	Repligen Corporation entered into an agreement and plan of merger to acquire BioLife Solutions, Inc. for approximately $1.6 billion.
22/07	Repligen beefs up cell therapy business with $1.5 billion deal for BioLife
22/07	Repligen to Acquire BioLife Solutions in $1.5 Billion Cash-and-Stock Deal
22/07	Repligen to Acquire BioLife Solutions in $1.5 Billion Cash-and-Stock Deal
22/07	Repligen to buy BioLife Solutions in $1.5 billion deal
22/07	Repligen to Acquire BioLife Solutions, Expanding Its Cell Therapy Capabilities with Market Leading Biopreservation Media
21/07	Deals of the day-Mergers and acquisitions
15/07	Repligen to Report Second Quarter 2026 Financial Results